Pioneering sustained drug delivery for management of chronic eye disease.

SpyGlass unites glaucoma and cataract treatment, bringing sustained drug delivery to a trusted surgical procedure.1

Treatment Gap

Where today's treatments fall short—and why a new approach is needed.

Our Solution

Discover how the BIM-IOL System integrates long-acting glaucoma therapy into cataract surgery.

The Data

Review clinical data on the safety, efficacy, and durability of the BIM-IOL System.

Where enduring vision becomes real


Experience the story behind enduring vision: a key opinion leader's perspective on the technology.

Please confirm you wish to leave
SpyGlassPharma.com

Please confirm you wish to open the SpyGlass LinkedIn page in another window.

Skip to content